Following Lupin’s launch of the first UK generic version of Fostair in August, Lupin UK general manager Ben Ellis tells Generics Bulletin how the company is taking full advantage of the opportunity and laying the groundwork for future activities in the respiratory arena.
Lupin broke new ground in the UK earlier this year, introducing at the end of August the country’s first generic version of Chiesi’s Fostair (beclometasone/formoterol) under the name Luforbec.
In the wake of that launch, Lupin UK general manager Ben Ellis has spoken to Generics Bulletin to set out...
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
